These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 33656625

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism.
    Adu TS, Mabandla MV.
    Metab Brain Dis; 2019 Dec; 34(6):1557-1564. PubMed ID: 31332728
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M, Haghdoost-Yazdi H, Sarbazi Golezari A, Babayan-Tazehkand A, Dargahi T, Rastgoo N.
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [Abstract] [Full Text] [Related]

  • 24. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y, Lin S, Wright C, Shen J, Carter K, Bhatt A, Fan LW.
    Neuroscience; 2016 Mar 24; 318():157-65. PubMed ID: 26777890
    [Abstract] [Full Text] [Related]

  • 25. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T, Eftekhari SM, Jamali-Raeufy N, Haghani S, Zeinali H, Roghani M.
    Exp Gerontol; 2017 Dec 15; 100():70-76. PubMed ID: 29107062
    [Abstract] [Full Text] [Related]

  • 26. Protective effect of plastrum testudinis extract on dopaminergic neurons in a Parkinson's disease model through DNMT1 nuclear translocation and SNCA's methylation.
    Ye S, Zhong J, Huang J, Chen L, Yi L, Li X, Lv J, Miao J, Li H, Chen D, Li C.
    Biomed Pharmacother; 2021 Sep 15; 141():111832. PubMed ID: 34153844
    [Abstract] [Full Text] [Related]

  • 27. Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson's Disease.
    Tsai WL, Chen HY, Huang YZ, Chen YH, Kuo CW, Chen KY, Hsieh TH.
    Behav Neurol; 2019 Sep 15; 2019():4829572. PubMed ID: 31885725
    [Abstract] [Full Text] [Related]

  • 28. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
    Jalewa J, Sharma MK, Gengler S, Hölscher C.
    Neuropharmacology; 2017 May 01; 117():238-248. PubMed ID: 28223210
    [Abstract] [Full Text] [Related]

  • 29. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ, Rauhala P, Tuominen RK, Liesi P.
    J Neurosci Res; 2006 Aug 15; 84(3):655-65. PubMed ID: 16810683
    [Abstract] [Full Text] [Related]

  • 30. Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.
    Carbone M, Duty S, Rattray M.
    BMC Neurosci; 2012 Apr 05; 13():38. PubMed ID: 22480308
    [Abstract] [Full Text] [Related]

  • 31. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y, Yoshimura R, Nakai K, Itakura T.
    Brain Res; 2002 Aug 30; 947(2):271-83. PubMed ID: 12176170
    [Abstract] [Full Text] [Related]

  • 32. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
    Sampaio TB, Pinton S, da Rocha JT, Gai BM, Nogueira CW.
    Eur J Pharmacol; 2017 Jan 15; 795():28-35. PubMed ID: 27915043
    [Abstract] [Full Text] [Related]

  • 33. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
    Barata-Antunes S, Teixeira FG, Mendes-Pinheiro B, Domingues AV, Vilaça-Faria H, Marote A, Silva D, Sousa RA, Salgado AJ.
    Int J Mol Sci; 2020 May 14; 21(10):. PubMed ID: 32422916
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S, Xu Y, Chen G, Ma K, Han C, Guo Z, Zhang Z, Ye K, Cao X.
    Neuropharmacology; 2015 Dec 14; 99():448-58. PubMed ID: 26282118
    [Abstract] [Full Text] [Related]

  • 36. Fumaria vaillantii extract protects PC12 cells against neurotoxicity induced by 6-OHDA.
    Javid H, Rahimian R, Salimi M, Haghani-Samani E, Farhadi M, Torkaman-Boutorabi A.
    Mol Biol Rep; 2024 Jun 17; 51(1):768. PubMed ID: 38884894
    [Abstract] [Full Text] [Related]

  • 37. Fraternine, a Novel Wasp Peptide, Protects against Motor Impairments in 6-OHDA Model of Parkinsonism.
    Biolchi AM, de Oliveira DGR, Amaral HO, Campos GAA, Gonçalves JC, de Souza ACB, Lima MR, Silva LP, Mortari MR.
    Toxins (Basel); 2020 Aug 27; 12(9):. PubMed ID: 32867207
    [Abstract] [Full Text] [Related]

  • 38. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY, Lee JE, Park JH, Shin IC, Koh HC.
    Toxicol Lett; 2012 Sep 18; 213(3):332-44. PubMed ID: 22842585
    [Abstract] [Full Text] [Related]

  • 39. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
    Dabbeni-Sala F, Di Santo S, Franceschini D, Skaper SD, Giusti P.
    FASEB J; 2001 Jan 18; 15(1):164-170. PubMed ID: 11149904
    [Abstract] [Full Text] [Related]

  • 40. The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease.
    Yu H, Liu X, Chen B, Vickstrom CR, Friedman V, Kelly TJ, Bai X, Zhao L, Hillard CJ, Liu QS.
    Cells; 2021 Dec 16; 10(12):. PubMed ID: 34944056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.